), generally Ͼ200 M (18, 19, 24-26, 29, 33, 37, 44, 45) and well above the physiological intracellular O 2 concentrations in those tissues. This along with the observation that oxidative deamination of biogenic amines via MAOs can be a significant source of hydrogen peroxide (H 2 O 2 ) involved in cell signaling (34, 41, 46) and oxidative injury (12, 14, 16, 51) suggests that the MAO O 2 sensitivity may be physiologically important. For example, the protective effect of MAO inhibition against central nervous system O 2 toxicity (51) and renal ischemia-reperfusion injury (16) has been attributed to the inhibition of the H 2 O 2 produced during MAO-mediated monoamine metabolism. However, there is a large discrepancy between the K m O2 for MAO from the several studies carried out with purified MAO (18, 19, [24] [25] [26] 29, 33, 37, 44, 45) and the apparent K m O2 (12-34 M) from the few studies carried out in cultured cells (26, 27) . This suggests that in addition to possible species and/or tissue (31, 52) differences, the sensitivity for O 2 may depend on the cellular MAO environment (9, 40, 52).
), generally Ͼ200 M (18, 19, 24-26, 29, 33, 37, 44, 45) and well above the physiological intracellular O 2 concentrations in those tissues. This along with the observation that oxidative deamination of biogenic amines via MAOs can be a significant source of hydrogen peroxide (H 2 O 2 ) involved in cell signaling (34, 41, 46) and oxidative injury (12, 14, 16, 51) suggests that the MAO O 2 sensitivity may be physiologically important. For example, the protective effect of MAO inhibition against central nervous system O 2 toxicity (51) and renal ischemia-reperfusion injury (16) has been attributed to the inhibition of the H 2 O 2 produced during MAO-mediated monoamine metabolism. However, there is a large discrepancy between the K m O2 for MAO from the several studies carried out with purified MAO (18, 19, 24-26, 29, 33, 37, 44, 45) and the apparent K m O2 (12-34 M) from the few studies carried out in cultured cells (26, 27) . This suggests that in addition to possible species and/or tissue (31, 52) differences, the sensitivity for O 2 may depend on the cellular MAO environment (9, 40, 52) .
The pulmonary endothelium is an important site of metabolism of certain monoamines present in the systemic venous return (15) and is subject to injury during high O 2 exposure (13) . This brings into question the influence of PO 2 on pulmonary endothelial monoamine metabolism and a possible contribution of MAO-generated H 2 O 2 to pulmonary hyperoxic injury. The discrepancy between results from purified enzymes and cell culture indicates that the O 2 dependency of MAO activity for cells residing in the intact organ cannot necessarily be predicted from studies on such reduced systems. Thus the objective of this study was to evaluate the O 2 dependency of the pulmonary endothelial MAO activity in intact lungs.
To this end, we developed a bolus injection multiple indicator dilution (MID) method for measuring MAO kinetics in the intact organ where the factors affecting substrate disposition can be more complex than in either cell culture or purified enzyme systems (2-6, 10, 22, 38) . Thus a key aspect of the approach is the ability to separate the kinetics of substrate-tissue interactions (e.g., membrane transport, enzymatic metabolism, nonspecific plasma and tissue protein interactions) from each other and from the kinematics of organ perfusion (e.g., perfusion heterogeneity, transit time distribution) (4, 6, 10, 38 (18, 19, 24-26, 29, 33, 37, 44, 45) and closer to that measured in cultured cells (26, 27) .
Glossary

B
Site of sequestration of PEA within cells C F (t) 3 H 2 O effluent concentration versus time curve C in (t) ϭ (q/F)h n (t)
Capillary input function C R (t) FITC-dextran (Dex) effluent concentration versus time curve C T (t)
Indicator concentration versus time outflow curve for perfusion tubing system without the lung h c (t)
Capillary transit time distribution h n (t) Noncapillary (arteries, veins, connecting tubing, and injection system) transit time distribution K 1 
Isolated Rabbit Lung Preparation
As previously described (3, 6) , each New Zealand White rabbit [2.68 Ϯ 0.16 (SD) kg; n ϭ 24; New Franken Research Rabbits, New Franken, WI] was given chlorpromazine hydrochloride (25 mg/kg im) followed by pentobarbital sodium (20-25 mg/kg) via an ear vein, heparinized (1200 IU/kg), and exsanguinated via a carotid artery catheter. After cannulation of the pulmonary artery and vein and the trachea, the lungs were removed from the chest and attached to the perfusion system primed with a physiological salt solution containing (in mM) 4.7 KCl, 2.51 CaCl2, 1.19 MgSO4, 2.5 KH2PO4, 118 NaCl, 25 NaHCO3, 5.5 glucose, and 4.5% bovine serum albumin (BSA) (3, 7) . The perfusion system included a perfusate reservoir and a MasterFlex roller pump that pumped the perfusate from the reservoir into the pulmonary artery. In the recirculation mode, the perfusate drained from the left atrium back into the reservoir. Pulmonary arterial (Pa) and venous (Pv) pressures referenced to the level of the left atrium were monitored continuously. The lung was ventilated with 5% CO2 and, depending on the experimental condition studied, either 95, 15, or 0% O 2 in N2 at 10 breaths/min with end-inspiratory and end-expiratory airway pressures of 7 and 2 cmH2O, respectively. Pulmonary arterial inflow and venous outflow PO 2 values were measured with a Radiometer (Copenhagen, Denmark) O2 electrode, and bolus injections were made when the respective PO2 values reached 488 Ϯ 10 (SE) and 548 Ϯ 15 Torr for 95% O 2, 107 Ϯ 2 and 105 Ϯ 2 Torr for 15% O2, and 20 Ϯ 2 and 12 Ϯ 2 Torr for 0% O 2, with a PCO2 of 36.8 Ϯ 6.0 (SD) Torr and pH of 7.36 Ϯ 0.07 (SD) at 35°C after the change to the respective gas mixtures. For subsequent evaluation of the O 2 dependency of MAO activity, the PO2 was taken to be the average of the inflow and outflow PO 2 values measured immediately before the injection and after the sample collection. Although for the high and low PO 2 values, the system had not completely equilibrated with the ventilating gas at the time the measurements were made, the values did not change significantly over the duration of the data collection period.
To produce a bolus injection, a solenoid-operated injection loop (3) was situated in the inflow tubing so that a 1.0-ml bolus could be introduced into the inflow stream without changing the flow or pressure. Just before the injection, the ventilator was stopped at end expiration and the venous outflow was directed into the sample tubes of a modified (3) Gilson Escargot fraction collector. One hundred 2-ml samples were collected at a sampling interval ranging from 0.3 to 2.4 s depending on the flow as described in Experimental Protocols.
After each experiment, the lungs were removed from the perfusion system, and additional bolus injections were made at the various flows studied, with the arterial and venous cannulas connected directly together. The data from these injections were used to obtain the concentration versus time curves [CT(t)] and moments thereof (3, 6, 7) for the passage of the bolus through the tubing from injection to fraction collector in the absence of the lungs at each of the flows studied.
Bolus Composition
The 1.0-ml bolus contained 2.5 mg of fluorescein isothiocyanate-labeled 40,000 molecular weight dextran (FITC-Dex) and 0. (43) .
Bio-Rex 70 cation-exchange resin (200-400 mesh) was washed and equilibrated to pH 6.0 with 0.05 M sodium phosphate buffer. The resin was packed to a bed height of 1 cm in a plastic Poly-Prep column (Bio-Rad). The lyophilized 1.0-ml samples were redissolved in 2.0 ml of the pH 6.0 buffer before being passed through the columns. This was followed by two 1.0-ml water washes, and the total effluent from each column, which contained mostly [ 14 C]PAA, was collected in a scintillation vial. The [ 14 C]PEA was eluted from each column with two 2.0-ml aliquots of 0.25 M HCl, and the effluent was collected in a separate scintillation vial. The 14 C counts in all samples were determined after the addition of 8 ml of Liquiscint (National Diagnostics, Atlanta, GA) on a Packard model 4530 liquid scintillation spectrometer. Recovery of 14 C was Ͼ95%. The crossovers of PAA into PEA and of PEA into PAA were Ͻ0.5 and Ͻ5%, respectively, as measured with standards treated as the samples. These percentages include the inherent crossover of the ion-exchange separation procedure and any metabolism that might have occurred in postcollection samples (1) . The venous effluent data measured after the bolus injection of [ 14 C]PEA under the various experimental conditions described in Experimental Protocols were cor-rected for the crossover of PAA into PEA and of PEA into PAA.
Experimental Protocols
The initial experiments were carried out under the various experimental conditions and protocols required to provide the information necessary for the development of the kinetic model and to evaluate the influence of PO 2 on the kinetics of the pulmonary disposition of PEA.
Flow. One experimental approach for separating the various processes affecting the pulmonary disposition of a given indicator is to vary the flow (2, 3, 6) , which, in turn, varies the time the injected indicators are in contact with the pulmonary endothelium. To determine a useful range of flows in this context, a bolus containing FITC-Dex and either Once it was determined, as indicated in Estimation of Model Parameters, that the effluent concentration versus time data at the two extremes of this flow range provided sufficient information to separately identify the kinetic parameters descriptive of the pulmonary disposition of PEA, two flows, 400 and 50 ml/min, were used in subsequent experiments.
MAO inhibition. To evaluate the role of MAO in the pulmonary metabolism of PEA and to provide a positive control for evaluating the ability of the kinetic analysis (see KINETIC MODEL) to distinguish between changes in PEA uptake and metabolism, experiments with the MAO inhibitors pargyline and semicarbazide (21, 43) were carried out by perfusing the lungs with perfusate containing 20 M pargyline and 1.0 mM semicarbazide for 5 min before the [ 14 C]PEA (n ϭ 4 lungs) or [ 14 C]PAA (n ϭ 1 lung) bolus injections at 400 and 50 ml/min and high PO 2. Pargyline (20 M) and semicarbazide (1.0 mM) were also included in the injected boluses. The pargyline and semicarbazide concentrations were chosen because they had been previously shown to completely inhibit [
14 C]PEA metabolism by perfused rabbit lungs (21, 43) .
Further evaluation of the separate effects of pargyline and semicarbazide on [
14 C]PEA metabolism was carried out in lungs perfused at 50 ml/min and ventilated with high O2 to provide the maximum window for detecting the effects of MAO inhibition. [ 14 C]PEA was injected before and after the lung was perfused with perfusate containing either pargyline (20 M) or semicarbazide (1.0 mM). Separate lungs were used for pargyline and semicarbazide, and the concentration of the MAO inhibitor in the injectate was the same as that in the perfusate during the injection-sampling period.
Varying PO2. The Pa and Pv values at 400 and 50 ml/min under the various experimental conditions studied are given in Table 2 . The pulmonary vascular volume (Q v ) and extravascular water volume (Q W ) calculated from the FITC-Dex, C R (t), 3 H 2 O, C F (t), and tubing C T (t) outflow curves (7) under the various experimental conditions studied were 8.6 Ϯ 1.3 (SD) and 6.8 Ϯ 1.4 ml, respectively, and were not significantly affected by experimental condition or flow.
KINETIC MODEL
Reactions
The metabolism of PEA to PAA is a two-step reaction (21, 43) where the first step involves the oxidative deamination of PEA to the intermediary metabolite phenylacetaldehyde via MAO and the second step involves the oxidation of phenylacetaldehyde to PAA via aldehyde dehydrogenase. The kinetic model developed in the present study for the pulmonary disposition of PEA and PAA assumes the MAO reaction to be the limiting step (28 PEA to PAA can be summarized by the following reaction
where
k ␣ is the MAO association rate constant. In addition to reaction a, the kinetic model assumes that PEA participates in the following reaction within the tissue
where B is the site of accumulation or sequestration of PEA within the cells (21, 43, 47) with the cell sequestration rate constant k ␤ . The PEA and PAA are also allowed to participate in nonspecific, rapidly equilibrating interactions with the perfusate BSA, on the luminal cell surface, and within the cells.
Single-Capillary Element
A single-capillary element of this model is composed of a capillary volume (Q c ) and an extravascular volume (Q e ) accessible to PEA or PAA. The spatial and tempo- 
‫͓ץ‬PAA c ͔ ‫ץ‬t ), which is the measure of the PEA sequestration rate within the lung tissue; PS 1 (ml/s) and PS 2 (ml/s), which are the endothelial permeabilitysurface area products for PEA and PAA, respectively;
) and k PAA (s Ϫ1 ), which are measures of the respective rate of PEA and PAA egress from the cells; and the virtual volumes Q 1 (ml) and Q 2 (ml), which are measures of the magnitude of the rapidly equilibrating cell surface interactions of PEA and PAA, respectively. For PAA injections, Eqs. 2-5 reduce to Eqs. 4 and 5 with PEA e set to zero, and the number of identifiable parameters reduces to three, namely PS 2 (ml/s), k PAA (s Ϫ1 ), and Q 2 (ml). The values of ␣ 1 and ␣ 2 were set at 1.14 and 9.1, respectively, based on the measured PEA-BSA and PAA-BSA binding.
Whole Organ
To construct an organ model from the single-capillary element model, the distribution of pulmonary capillary transit times [h c (t)] needs to be taken into account (4-6, 10, 38). Previously, Audi et al. (5) estimated that for normal rabbit lungs in this perfusion system, the mean transit time (t c ) of the h c (t) was ϳ44% of the total vascular mean transit time, the relative dispersion of h c (t) (RD c ϭ c /t c ) was ϳ0.9; and the skewness coefficient of h c (t) (m c 3 / c 3 ) was ϳ2, where m c 3 and c are the third central moment and standard deviation of h c (t), respectively. For the analysis described in Estimation of Model Parameters, we used these values to approximate h c (t) using a shifted random walk function as previously described (4-6). The capillary transit time distribution was accounted for by first discretizing h c (t) into a finite number of capillary transit times as previously described (4, 6). The organ output for a given indicator was then obtained by summing the corresponding solutions of Eqs. 1-5 for all these capillary transit times, each weighted according to h c (t) (4) .
Estimation of the kinetic model parameters described in Estimation of Model Parameters involved numerically [finite difference method (4)] solving Eqs. 1-5 for the appropriate boundary conditions at each iteration of a Levenberg-Marquardt optimization routine (35) . The time step was chosen by successively halving an initial time step until the coefficients of variation between the solutions of Eqs. 1-5 at successive time steps was Ͻ2%.
Estimation of Model Parameters
Preliminary investigation of the kinetic model behavior revealed that data from a single bolus injection are not sufficient to robustly estimate all of the identifiable model parameters. Previously, Audi et al. (2, 3, 6) demonstrated the utility of manipulating flow to reduce correlations between model parameters. In the present study, the range of flows studied was chosen as follows. Initial injections at 400 ml/min, which is in the range of rabbit cardiac output [ϳ340 ml/min for a 2.7-kg rabbit (5)], revealed that the outflow concentration curves after [ 14 C]PEA injections are dominated by information about PEA uptake while providing relatively little information on metabolism (Fig. 1A) . We progressively reduced the flow until most of the effluent 14 C]PEA. This occurred by 50 ml/min as seen in Fig. 1D . Therefore, the outflow curves measured at 400 and 50 ml/min after [ 14 C]PAA bolus injections at 400 and 50 ml/min. C in (t) ϭ (q/Q )h n (t) is the capillary input concentration curve (2) (3) (4) (5) (6) , where h n (t) is the noncapillary (arteries, veins, connecting tubing, and the injection system) transit time distribution, and q and Q are the mass of the injected indicator and total flow through the organ, respectively. C in (t) is related to the vascular reference indicator curve C R (t) and the h c (t) by the convolution relationship C R (t) ϭ C in (t)*h c (t) as previously described (2-6). Table 3 shows the estimates of the PAA model parameters and measures of precision of these estimates, namely the 95% confidence intervals and the correlation matrix (3, 30) . To determine whether the values of the PAA model parameters were affected by any of the experimental conditions, we compared the model fit obtained using the parameter values estimated from each individual experiment with the fit obtained using the mean set of PAA model parameters values estimated from all the PAA experiments given in Table 3 . The F ratios (36) indicated that the fits to the individual data sets using the mean parameters were not significantly worse than those using individual parameters estimated from each data set. Thus it is concluded that any effects of the different experimental conditions were not detectable, and the kinetic model parameters descriptive of the pulmonary disposition of PAA were set to the mean values of 0.27 ml/ml of vascular volume, 0.063 s Ϫ1 , and 0.50 ml ⅐ s Ϫ1 ⅐ ml Ϫ1 of vascular volume for PS 2 /Q v , k PAA , and Q 2 /Q v , respectively. The normalization to the Q v measured for each lung is to accommodate small differences in lung sizes.
Knowing the PAA kinetic parameters, the parameters descriptive of PEA disposition, namely k met (s Table 4 shows the estimated values of the PEA model parameters and measures of precision of these estimates (3, 30) under the various experimental conditions studied. The resulting model fit is exemplified in Figs. 2 and 4 . The estimated values of the PEA model parameters are also shown in Table 5 , where the extensive parameters PS 1 and Q 1 were normalized to the Q v to account for small differences in lung sizes. With pargyline and semicarbazide treatment, k met became undetectable with little effect on PS 1 . The effects on k seq and Q 1 were small but significant. In the range from 518 to 106 Torr, PO 2 had no significant effect on the PEA kinetic parameters (Table 5) . However, at PO 2 ϭ 16 Torr, the estimated value of k met was significantly smaller than that estimated at the higher PO 2 levels. The effect of PO 2 ϭ 16 Torr on k seq was also significant. The apparent K m O2 for MAO in the intact lung was estimated from k met ϭ [(k met ) max PO 2 ]/(PO 2 ϩ K m O2 ) (Fig. 5) , where (k met ) max is the maximum k met . The value was 17.0 Torr (18.2 M).
DISCUSSION
The results indicate that the apparent K m O2 for MAO in the intact lung is significantly smaller than that estimated from studies carried out with purified MAO (18, 19, 24-26, 29, 33, 37, 44, 45) and closer to that estimated from studies carried out in cultured cardiac myocytes (27) and hepatocytes (26) . The value is well below normal alveolar PO 2 , suggesting a minimal influence of PO 2 on lung MAO activity. The results are consistent with differences in the activities and specificities of enzymes in general (8, 49) and of MAO in particular (9, 49) in their in situ cellular environments versus the purified enzymes. Although the estimated value of K m O2 is much smaller than most of those estimated for purified MAO and probably not relevant in the hyperoxic range, it is still in a range high enough for sensing changes in O 2 in the hypoxic range. Furthermore, the results do not preclude an important role for MAO-generated H 2 O 2 in the face of increased plasma concentrations of biogenic amines over any range of PO 2 values (23, 51).
The O 2 concentrations used to estimate K m O2 (Fig. 5 ) were measured in the perfusate. These values may be higher than the O 2 concentrations near the outer mitochondrial membrane site of MAO under the assumption that the mitochondria are sinks for O 2 . However, in the lungs, where the rate of metabolism is low compared with the rate of gas transport across the alveolar capillary barrier and where diffusion distances are small, the expectation is that the local PO 2 is not much lower than the perfusate PO 2 (27) . Thus although the estimated K m O2 in this sense represents an upper bound on the actual K m O2 , the difference is probably quite small and in the direction of increasing the discrepancy between intact lungs and purified enzymes. Previous studies (19, 27) on the O 2 dependency of the MAO reaction have demonstrated that the K m O2 is also somewhat sensitive to the monoamine substrate concentration, consistent with the nature of the MAO reaction mechanism (19, 27) . In the present study, the estimate is for tracer PEA concentration. One aspect of studies on intact organs and cells that distinguishes them from studies on purified enzymes is that the rate of entry into the cells needs to be accounted for. In the above model, PEA uptake is represented by a linear transport mechanism (9) having a permeabilitysurface area product (PS 1 ). Previous investigations (21, 48) have concluded that this mechanism is passive diffusion. Given the relatively low lipid solubility of PEA, its extensive pulmonary uptake via passive diffusion is somewhat surprising (48) . The data in Figs. 1-4 and the relative rates of uptake and metabolism indicate that the intracellular concentration of PEA during bolus passage became much greater than the vascular concentration. This would be consistent with a large PEA tissue-toperfusate partition coefficient, which in the model would be a large ␣ 3 Q e -to-␣ 1 Q c ratio. Alternatively, if an active uptake mechanism were involved, the model representation would be a larger permeability-surface area product for PEA uptake (PS 1 ) than for egress, the latter being lumped with other processes in the group parameter k PEA . These two effects are not separable with the data obtained in the present study. However, with additional experimental protocols, the kinetic model and the MID method developed in the present study may be useful for further evaluation of the underlying PEA uptake mechanism.
Another difference between studies with intact organs or cells and studies with purified enzymes is that in intact organs and cells, competing processes such as substrate interactions with perfusate constituents (e.g., plasma proteins) and with any number of cellular and/or tissue constituents can also affect substrate availability by altering its partitioning within the cells and between the medium (perfusate) and the cells. These factors are represented in the model by Q 1 and Q 2 for nonspecific cell surface and/or tissue interactions, ␣ 1 and ␣ 2 for perfusate albumin interactions, and ␣ 3 , ␣ 4 , and k seq for intracellular interactions.
The major difference between intact organs and isolated cells is that in the intact organ, access to the cells is generally via the vascular system, which further complicates the evaluation of intracellular functions. For example, changing the flow by itself has a substantial effect on the extracted fraction of PEA (Fig. 1) , and at a given flow, the overall extraction fraction is determined by contributions from the capillary pathways with different flows and/or transit times (4, 5, 10) and hence different extraction fractions. This is taken into account in the model by allowing for longitudinal spatial variations in the concentration of the injected indicators within a given capillary element (Eqs. [1] [2] [3] [4] [5] , by representing the organ by parallel capillary elements with different transit times (4) , and by weighing the contributions of these capillary elements according to h c (t) as previously discussed in more detail (4) .
Previous studies (21, 43) have concluded that the endothelium is the main site for the MAO responsible for the oxidative deamination of PEA in the lung. Three forms of MAO have been identified in the rabbit lung (20, 21, 42, 43) , including MAO-A, MAO-B, and a semicarbazide-sensitive form (SSMAO), with distinct subcellular localizations and substrate and/or inhibitor affinities. MAO-A and MAO-B are both located on the outer mitochondrial membrane (20, 21, 32, 42, 43) , but MAO-A has a higher affinity for serotonin and norepinephrine and is selectively inhibited by clorgyline (21, 43) , whereas MAO-B has a higher affinity for PEA and is more sensitive to inhibition by pargyline (21, 43) . PEA is also a substrate for SSMAO, which is thought to be located on the plasma membrane (11, 17, 21, 43, 50) . Roth and Gillis (43) and Gillis and Roth (21) found that treatment with pargyline followed by the addition of semicarbazide reduced PEA metabolism by 70 and ϳ100%, respectively. This is consistent with the results in the present study where treatment with pargyline alone decreased the fractional recovery of [ (Fig. 3C ) and that treatment with both pargyline and semicarbazide was needed for full inhibition (Fig. 2) . However, the lack of effect of semicarbazide alone on PEA metabolism (Fig. 3B) 
‫͓ץ‬PAA c ͔ ‫ץ‬t
where k met2 (ml/s) is a measure of the rate of PEA metabolism by SSMAO. The value of k met2 was estimated by fitting the solution of Eqs. 3 and 5-7 to the (Fig.  3C) . The identifiable parameters were k met2 and k seq , with k met set to zero and the other parameters set to the mean values in Table 3 (PO 2 ϭ 518 Torr). The estimated value of k met2 was 0.31 ml/s, which is much smaller than the ϳ16 ml/s estimated for PEA uptake (PS 1 ). This result indicates that as long as there is significant PEA uptake and sufficient PEA metabolism by pargyline-sensitive MAO, the data will be insensitive to the contribution of SSMAO to PEA metabolism. That explains why semicarbazide alone did not have a detectable effect on PEA metabolism (Fig. 3B) . It also indicates that the apparent K m O2 estimated is for pargyline-sensitive MAO because the high rate of PEA uptake over the range of PO 2 studied (16-518 Torr) makes the SSMAO contribution negligible under the study conditions.
The kinetic model represented by Eqs. 2-5 allows for the previously observed PEA sequestration within the cells (21, 43, 47) . Table 1 (Fig. 1C) . After treatment with MAO inhibitors, metabolism was no longer competing with sequestration for [ 14 C]PEA, and hence a larger fraction of the PEA taken up was sequestrated and a smaller fraction of the injected 14 C was recovered in the venous effluent. This competition between intracellular PEA metabolism and sequestration was not detectable at 400 ml/min (Table 1) ]PEA injections at 400 and 50 ml/min are shown in Fig. 6 . For the ith model parameter i , S i (t) ϭ ‫ץ‬C(t)/‫ץ‬ i , where C(t) is the calculated PEA or PAA indicator effluent concentration. The sensitivity function S i (t) was approximated by the change in C(t) resulting from a 1% change in i divided by the change in i (6) . Multiplying S i (t) by the value of the parameter estimate, i , provides an indication of the relative contribution of the parameter to the model fit to the data at a given time (6) . Comparison of these normalized sensitivity functions reveals the extent and the time epoch to which the optimized model parameters make their contributions to the model fit. The shapes of the sensitivity function relative to each other reveal how independent the contributions of the individual parameters are to the model fit. For example, at 400 ml/min, the dominant role of PEA uptake in the model fit is revealed by the sensitivity function of PS 1 (Fig. 6A) . The contribution of k met at 400 ml/min is small relative to that for PS 1 (Fig. 6A) . At 50 ml/min, on the other hand, k met plays a dominant role, whereas the contribution of PS 1 is relatively small (Fig. 6D) . Thus fitting the model to the data at both flows reduces the correlation between model parameters by increasing the extent of their contributions to the model fit to the data and by extending and segregating the time epochs over which they make their contributions. For the above analysis, the data at only the 400 and 50 ml/min flows were utilized for parameter estimation. However, in several experiments, data were collected at four flows within the same flow range (Fig. 1) . As one measure of the robustness of the above parameter estimation approach, we determined whether dividing up the flow range into the four smaller increments would have a significant impact on the estimated values of the model parameters. To this end, the PEA model parameters estimated by simultaneously fitting the solution of Eqs. [1] [2] [3] [4] [5] Table 6 ).
The MID method has been used to measure intracellular reactions in organs such as the heart (10) and liver (38) . Although widely used in the lungs for measuring tissue composition (4, 7), transcapillary transport (2, 15, 22) , and reactions that take place at the luminal endothelial surface (6, 15) , its use for studying intracellular metabolism in the lungs has been limited (6, 7). The kinetic model represented by Eqs. 1-5 is similar to the one used by Pang et al. (38) to evaluate the intracellular metabolism of acetaminophen in the intact liver. The kinetic model and experimental protocol developed in the present study establish a basis for utilizing the MID method for evaluating intracellular functions such as MAO activity in the intact lung. The present results with this approach suggest a minimal influence of O 2 concentration on the MAO reaction in the normal rabbit lung.
